New NGOs Crank Up the Pace for Psychedelic Access – US and Worldwide

The Psychedelic Space continues to pop. Two fresh announcements in 2022, one from Amanda Fielding, Director of the UK-based Beckley Foundation, the other from Washington DC-based Psychedelic Medicine Coalition (PMC), testify to the groundswell underway. Fielding is a high-profile figurehead/philanthropist. The global reform effort by newly-formed “ITPRI” is also supported by MAPS, yet only seeks to reschedule psilocybin.

Big capital now moves into a space that once upon a time was populated by hippies like Cheech and Chong and other outcasts.

As is now becoming a banal statistic, total investments in both for-profits and NGOs exploring psychedelia hover in the billion-dollar zone. This is enough to spawn multiple “market reports” for a “market” that won’t even exist, in true legal form, for years. Some percentage of the TSX startups will presumably wind up being little more than corporate pump&dump schemes – perhaps the subject of a future post here at TrialSite’s investor watch. 

To quote an anonymous twitter post: “Psychedelic medicalization: that sweet spot between prohibition and legalization where psychedelics will still be criminalized for most of us but co…

Quality journalism costs money to produce. We will be reinvesting the proceeds of these subscriptions into an increasing volume of high quality, independent, unbiased reporting and expert analysis. Our subscription tiers use the ‘honor system’  – please do not abuse it. All tiers of service provide the same level of access to content.  We are grateful for all of you, and we hope you reciprocate.

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

TrialSite Staff

Read Source